261 related articles for article (PubMed ID: 17080227)
1. Fibrinogen Darlinghurst: hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications.
Sheen CR; Low J; Joseph J; Kotlyar E; George PM; Brennan SO
Thromb Haemost; 2006 Nov; 96(5):685-7. PubMed ID: 17080227
[No Abstract] [Full Text] [Related]
2. Paradoxical bleeding and thrombosis in a patient with afibrinogenemia and fibrinogen Mumbai mutation.
Mukaddam A; Patil R; Jadli A; Chandrakala S; Ghosh K; Shetty S
Am J Clin Pathol; 2015 May; 143(5):755-7. PubMed ID: 25873512
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias.
Hill M; Dolan G
Haemophilia; 2008 Sep; 14(5):889-97. PubMed ID: 18564189
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Tolaga Bay: a novel gammaAla341Val mutation causing hypofibrinogenaemia.
Davis RL; Brennan SO
Thromb Haemost; 2007 Nov; 98(5):1136-8. PubMed ID: 18000621
[No Abstract] [Full Text] [Related]
5. Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation.
Zdziarska J; Undas A; Basa J; Iwaniec T; Skotnicki AB; de Moerloose P; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):374-6. PubMed ID: 19300242
[TBL] [Abstract][Full Text] [Related]
6. Bbeta 14 Arg --> Cys variant dysfibrinogen and its association with thrombosis.
Castaman G; Ghiotto R; Tosetto A; Rodeghiero F
J Thromb Haemost; 2005 Feb; 3(2):409-10. PubMed ID: 15670063
[No Abstract] [Full Text] [Related]
7. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis.
Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy.
Miesbach W; Galanakis D; Scharrer I
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502
[TBL] [Abstract][Full Text] [Related]
9. Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a gamma320Asp deletion at the Ca2+ binding site.
Brennan SO; Davis RL; Mosesson MW; Hernandez I; Lowen R; Alexander SJ
Thromb Haemost; 2007 Aug; 98(2):467-9. PubMed ID: 17721633
[No Abstract] [Full Text] [Related]
10. Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendency.
Zawilska K; Undas A; Fish RJ; Molendowicz-Portala L; De Moerloose P; Neerman-Arbez M
Thromb Haemost; 2010 Mar; 103(3):677-9. PubMed ID: 20135062
[No Abstract] [Full Text] [Related]
11. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
[TBL] [Abstract][Full Text] [Related]
12. Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation.
Berens C; Rühl H; Ivaškevičius V; Oldenburg J; Hertfelder HJ; Pötzsch B
Thromb Haemost; 2016 May; 115(5):1073-5. PubMed ID: 26763372
[No Abstract] [Full Text] [Related]
13. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N
Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation.
de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW
Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237
[TBL] [Abstract][Full Text] [Related]
15. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
[TBL] [Abstract][Full Text] [Related]
16. Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation.
Brennan SO; Mosesson MW; Lowen R; Frantz C
Thromb Haemost; 2006 Jul; 96(1):88-9. PubMed ID: 16807657
[No Abstract] [Full Text] [Related]
17. Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - gamma 82 Ala-->Gly and an intron two GT-->AT splice site mutation.
Wyatt J; Brennan SO; May S; George PM
Thromb Haemost; 2000 Sep; 84(3):449-52. PubMed ID: 11019970
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Columbus III: A novel c.963del frameshift mutation in the FGG gene resulting in hypofibrinogenemia with a bleeding phenotype.
Abdelghani E; Dawson J; Zajo K; Hallam M; Dunn A; Kumar R
Pediatr Blood Cancer; 2021 Mar; 68(3):e28713. PubMed ID: 33058516
[No Abstract] [Full Text] [Related]
19. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
Castaman G; Giacomelli SH; Duga S; Rodeghiero F
Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
[No Abstract] [Full Text] [Related]
20. Congenital fibrinogen disorders with repeated thrombosis.
Zhang X; Zhang C; Wang B; Chen N; Sun G; Guo X
J Thromb Thrombolysis; 2020 Feb; 49(2):312-315. PubMed ID: 31542854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
